Abstract:
The present invention relates to the use of trifluoroacetylated lysine (Boc-L-Lys(e- trifluoroacetyl)-MCA) as a substrate for histone deacetylases, specific for the class Ha subtype.
Abstract:
Compounds of formula I: are potent and selective antagonists of the 5-HT 2A receptor, and hence are useful in treatment of various 10 CNS disorders.
Abstract:
Compounds of formula (I) or a pharmaceutically acceptable salt thereof; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating the glucocorticoid receptor in a warm blooded animal).
Abstract:
The present invention relates in part to compounds of formulas I and III: and pharmaceutically-acceptable salts and prodrugs thereof. These compounds can be useful for treating diseases such as inflammatory and immune diseases. The present invention also relates to pharmaceutical compositions comprising these compounds, and to methods of inhibiting inflammation or suppressing immune response in a subject.
Abstract:
The invention relates to the use of aromatics sulfonamides of the general formula (I) as peroxynitrite rearrangement catalysts, to the preparation thereof and to the use thereof as medicament for the treatment of various disorders.
Abstract:
Compounds of Formula (I), are provided where T is CHO, COR 8 , or C(OH)R 1 R 2 ; R 1 and R 2 are hydrogen, optionally substituted lower alkyl, CF 3 , optionally substituted alkenyl, or optionally substituted alkynyl; R 3 is hydrogen or optionally substituted lower alkyl; R 4 is (CF 3 ) n alkyl, (CF 3 ) n (substitutedalkyl), (CF 3 ) n alkylphenyl, (CF 3 )nalkyl(substitutedphenyl), or (F) n cycloalkyl; n=1-3; R 5 is hydrogen, halogen, CF 3 , diene fused to Y when Y=C, or substituted diene fused to Y when Y=C; W, Y and Z are C, CR 6 or N where at least one of W, Y or Z are C; R 6 is hydrogen, halogen, or optionally substituted lower alkyl; X is O, S, SO 2 , or NR 7 ; R 7 is hydrogen, optionally substituted lower alkyl, optionally substituted benzyl, or optionally substituted phenyl; and R 8 is lower alkyl, CF 3 , or optionally substituted phenyl. Methods of preparing and using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's Disease and Down's syndrome are also described.
Abstract translation:提供式(I)化合物,其中T是CHO,COR8或C(OH)R 1 R 2; R 1和R 2是氢,任选取代的低级烷基,CF 3,任选取代的烯基或任选取代的炔基; R3是氢或任选取代的低级烷基; R4是(CF3)n烷基,(CF3)n(取代烷基),(CF3)n烷基苯基,(CF3)n烷基(取代苯基)或(F)n环烷基; N = 1-3; 当Y = C时,R 5为氢,卤素,CF 3,与Y稠合的二烯,或Y = C时与Y稠合的取代二烯; W,Y和Z是C,CR 6或N,其中W,Y或Z中的至少一个是C; R6是氢,卤素或任选取代的低级烷基; X是O,S,SO 2或NR 7; R 7是氢,任选取代的低级烷基,任选取代的苄基或任选取代的苯基; 且R 8为低级烷基,CF 3或任选取代的苯基。 还描述了制备和使用这些化合物抑制β-淀粉样蛋白产生和治疗阿尔茨海默病和唐氏综合征的方法。
Abstract:
The present invention relates to compounds of formula (AA), (I) and (X), useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation.
Abstract:
Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of inflammatory and immune-related diseases and conditions. In particular, the invention provides compounds which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer. The subject compounds are carboxylic acid derivatives.